Prognostic value of plasminogen activator inhibitor‐1 in biomarker exploration using multiplex immunoassay in patients with metastatic renal cell carcinoma treated with axitinib

BACKGROUND AND AIMS: Vascular endothelial growth factor‐directed therapies play a significant role in patients with metastatic renal cell carcinoma (mRCC). Biomarkers for predicting treatment efficacy and resistance are required to develop personalized medicine. We evaluated multiple serum cytokine...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Health Sci Rep
Glavni autori: Honma, Naoko, Inoue, Takamitsu, Tsuchiya, Norihiko, Koizumi, Atsushi, Yamamoto, Ryohei, Nara, Taketoshi, Kanda, Sohei, Huang, Mingguo, Numakura, Kazuyuki, Saito, Mitsuru, Narita, Shintaro, Satoh, Shigeru, Habuchi, Tomonori
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7559632/
https://ncbi.nlm.nih.gov/pubmed/33088925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hsr2.197
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items